{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:24:06Z","timestamp":1788985446566,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001698","name":"Israel Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001698","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmig.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Minimally Invasive Gynecology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jmig.2020.11.023","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T02:33:20Z","timestamp":1606444400000},"page":"947-956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Endometrial Cancer in Germline BRCA Mutation Carriers: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6990-9592","authenticated-orcid":false,"given":"Emad","family":"Matanes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Volodarsky-Perel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neta","family":"Eisenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misgav","family":"Rottenstreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Yasmeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mitric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susie","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter H.","family":"Gotlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liron","family":"Kogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmig.2020.11.023_bib0001","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10689-011-9506-2","article-title":"Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations","volume":"11","author":"Moran","year":"2012","journal-title":"Fam Cancer"},{"key":"10.1016\/j.jmig.2020.11.023_bib0002","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cncr.29041","article-title":"Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian [published correction appears in Cancer. 2015;121:2474\u20132475]","volume":"121","author":"Mersch","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jmig.2020.11.023_bib0003","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jmig.2020.11.023_bib0004","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ygyno.2005.05.002","article-title":"Society of gynecologic oncologists clinical practice committee statement on prophylactic salpingo-oophorectomy","volume":"98","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.11.023_bib0005","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Genetic\/familial high-risk assessment: breast, ovarian and pancreatic. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx. Accessed December 8, 2020."},{"key":"10.1016\/j.jmig.2020.11.023_bib0006","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jmig.2020.11.023_bib0007","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ygyno.2012.09.012","article-title":"Uterine papillary serous cancer: a review of the literature","volume":"127","author":"del Carmen","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.11.023_bib0008","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/cncr.31842","article-title":"Uterine cancer in Jewish Israeli BRCA1\/2 mutation carriers","volume":"125","author":"Laitman","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.jmig.2020.11.023_bib0009","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/jamaoncol.2016.1820","article-title":"Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations","volume":"2","author":"Shu","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jmig.2020.11.023_bib0010","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/IGC.0000000000000402","article-title":"Endometrial cancers in mutation carriers from hereditary breast ovarian cancer syndrome kindreds: report from the Creighton University Hereditary Cancer Registry with review of the implications","volume":"25","author":"Casey","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jmig.2020.11.023_bib0011","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/modpathol.2012.169","article-title":"Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriers","volume":"26","author":"Reitsma","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jmig.2020.11.023_bib0012","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jnci\/djx159","article-title":"Risk of serous endometrial carcinoma in women with pathogenic BRCA1\/2 variant after risk-reducing salpingo-oophorectomy","volume":"110","author":"Saule","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmig.2020.11.023_bib0013","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jmig.2020.11.023_bib0014","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of observational studies in epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jmig.2020.11.023_bib0015","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jmig.2020.11.023_bib0016","unstructured":"Wells GA, Shea B, O'Connell et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed December 8, 2020."},{"key":"10.1016\/j.jmig.2020.11.023_bib0017","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1525-1438.2007.01030.x","article-title":"Prolonged survival among women with BRCA germline mutations and advanced endometrial cancer: a case series","volume":"18","author":"Kwon","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jmig.2020.11.023_bib0018","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Breast Cancer Linkage Consortium. Cancer Incidence in BRCA1 mutation carriers","volume":"94","author":"Thompson","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmig.2020.11.023_bib0019","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2006.08.004","article-title":"The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study","volume":"104","author":"Beiner","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.11.023_bib0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2013.03.027","article-title":"The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study","volume":"130","author":"Segev","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.11.023_bib0021","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2017.07.004","article-title":"Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers","volume":"84","author":"Lee","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jmig.2020.11.023_bib0022","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s12094-018-1865-9","article-title":"Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study","volume":"20","author":"Minig","year":"2018","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.jmig.2020.11.023_bib0023","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/gyno.2000.6082","article-title":"Risk of endometrial carcinoma associated with BRCA mutation","volume":"80","author":"Levine","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.11.023_bib0024","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cncr.27720","article-title":"BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma","volume":"119","author":"Pennington","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jmig.2020.11.023_bib0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/gyno.2000.6003","article-title":"Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?","volume":"79","author":"Goshen","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.11.023_bib0026","first-page":"1531","article-title":"BRCA germline mutations in women with uterine serous carcinoma\u2013still a debate","volume":"20","author":"Lavie","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jmig.2020.11.023_bib0027","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/IGC.0b013e3181ef622d","article-title":"BRCA1\/2 germline mutations in Jewish patients with uterine serous carcinoma","volume":"20","author":"Bruchim","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jmig.2020.11.023_bib0028","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ygyno.2018.10.019","article-title":"Cancer susceptibility gene mutations in type I and II endometrial cancer","volume":"152","author":"Long","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.11.023_bib0029","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ygyno.2008.08.035","article-title":"Relationship between tamoxifen use and high risk endometrial cancer histologic types","volume":"112","author":"Bland","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.11.023_bib0030","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/bjs.10899","article-title":"Meta-analysis of the cumulative risk of endometrial malignancy and systematic review of endometrial surveillance in extended tamoxifen therapy","volume":"105","author":"Fleming","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.jmig.2020.11.023_bib0031","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ygyno.2017.03.025","article-title":"Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous\/serous-like uterine cancers in BRCA1 mutation carriers","volume":"145","author":"Havrilesky","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.11.023_bib0032","doi-asserted-by":"crossref","first-page":"490.e1","DOI":"10.1016\/j.ajog.2013.06.018","article-title":"Surgical site infection after hysterectomy","volume":"209","author":"Lake","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2020.11.023_bib0033","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/AOG.0000000000002414","article-title":"Urinary tract injury in gynecologic laparoscopy for benign indication: a systematic review","volume":"131","author":"Wong","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2020.11.023_bib0034","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/AOG.0000000000002852","article-title":"Vaginal cuff dehiscence and evisceration: a review","volume":"132","author":"Nezhat","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2020.11.023_bib0035","first-page":"413","article-title":"ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer","volume":"106","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2020.11.023_bib0036","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijgo.2003.12.001","article-title":"Abnormal uterine bleeding and prognosis of endometrial cancer","volume":"85","author":"Kimura","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jmig.2020.11.023_bib0037","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/1471-2407-9-460","article-title":"The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study","volume":"9","author":"Seebacher","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jmig.2020.11.023_bib0038","series-title":"SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics","author":"Ries","year":"2007"}],"container-title":["Journal of Minimally Invasive Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465020311419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465020311419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:40:51Z","timestamp":1761558051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553465020311419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1553465020311419"],"URL":"https:\/\/doi.org\/10.1016\/j.jmig.2020.11.023","relation":{},"ISSN":["1553-4650"],"issn-type":[{"value":"1553-4650","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endometrial Cancer in Germline BRCA Mutation Carriers: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Minimally Invasive Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmig.2020.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AAGL. All rights reserved.","name":"copyright","label":"Copyright"}]}}